Self-Administered Drug Exclusion List (A53032) - R27 - Effective November 01, 2022

This coverage article has been revised and published for notice under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).

Effective Date: November 01, 2022

Summary of Changes: The article is updated to add: Adbry™ (tralokinumab-ldrm) - C9399, J3490, J3590 effective 11/01/2022.

The most current version of the Self-Administered Drug Exclusion List is available on the Medicare Coverage Database (MCD).

To view the complete listing of  coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Medicare Coverage Articles webpage.

 

Last Updated Sep 09 , 2022